Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015

NEW YORK, July 9, 2015 /PRNewswire/ -- Rodman & Renshaw Conferences, LLC is hosting The Rodman & Renshaw Annual Global Investment Conference on September 8 through September 10, 2015 at the St. Regis Hotel in New York.  More than 200 public & private companies from around the world are expected to present to an audience of over 2,000 attendees.  The event will feature tracks devoted to Biotechnology/Healthcare, Metals & Mining, Technology, Cleantech and Growth.  The Conference will include corporate presentations and Q&A sessions, investor one-on-one meetings and daily networking opportunities.  Institutional investors, venture capitalists, private equity firms, sophisticated private investors and industry executives are welcome to attend this conference.  Register online at the Rodman & Renshaw Conference website at www.rodmanevents.com  or contact Lily Khaykina, Rodman & Renshaw's Conference Manager, at (212) 356-0529 or via e-mail at LK@rodmanevents.com

Presenting Companies (partial list)

22nd Century Group, Inc. (NYSE MKT: XXII)
Abeona Therapeutics, Inc. (NASDAQ: PTBI)
Accurexa Inc. (OTCQB: ACXA)
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
Acme United Corporation (NYSE MKT: ACU)
Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM))
Active Power, Inc. (NASDAQ: ACPW)
ADMA Biologics, Inc. (NASDAQ: ADMA)
Aeterna Zentaris Inc. (NASDAQ: AEZS)
Aethlon Medical, Inc. (OTC BB: AEMD)
Agenus Inc. (NASDAQ: AGEN)
Alliqua BioMedical, Inc. (NASDAQ: ALQA)
Amarin Corporation plc (NASDAQ: AMRN)
American DG Energy Inc. (NYSE MKT: ADGE)
AmpliPhi Biosciences Corporation (OTCQB: APHB)
Apricus Biosciences, Inc. (NASDAQ: APRI)
Arch Therapeutics, Inc. (OTCQB: ARTH)
Arno Therapeutics, Inc. (OTC BB: ARNI)
Asterias Biotherapeutics, Inc. (NYSE MKT: AST)
Atossa Genetics Inc. (NASDAQ: ATOS)
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH)
Avino Silver & Gold Mines Ltd. (NYSE MKT: ASM)
Bacterin International (NYSE: BONE)
Bio Blast Pharma Ltd. (NASDAQ: ORPN)
Bio-Path Holdings, Inc. (NASDAQ: BPTH)
Biocept, Inc. (NASDAQ: BIOC)
BioLife Solutions, Inc. (NASDAQ: BLFS)
BioLineRx Ltd. (NASDAQ: BLRX)
Bionomics Ltd. (ASX & OTCQX respetively: BNO & BNOEF)
BioSpecifics Technologies Corp. (NASDAQ: BSTC)
Biota Pharmaceuticals, Inc. (NASDAQ: BOTA)
BioTime, Inc. (NYSE MKT: BTX)
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)
Capnia, Inc. (NASDAQ: CAPN)
Cardiome Pharma Corp. (NASDAQ: CRME)
CASI Pharmaceuticals, Inc. (NASDAQ: CASI)
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX)
Ceapro Inc. (TSX: CZO.V)
Celator Pharmaceuticals, Inc. (NASDAQ: CPXX)
Celsion Corporation (NASDAQ: CLSN)
Cesca Therapeutics Inc. (NASDAQ: KOOL)
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
China Recycling Energy Corporation (NASDAQ: CREG)
Clean Diesel Technologies, Inc. (NASDAQ: CDTI)
Cleveland BioLabs, Inc. (NASDAQ: CBLI)
Codexis, Inc. (NASDAQ: CDXS)
CombiMatrix Corporation (NASDAQ: CBMX)
ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV)
CorMedix Inc. (NYSE MKT: CRMD)
Cortendo AB (OTC: CRTOF)
Critical Outcome Technologies Inc. (TSXV; OTCQB: COT.V; COTQF)
Curemark LLC
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC)
Cynapsus Therapeutics Inc. (TSX & OTCQX: CTH.TO & CYN)
Cynata Therapeutics Limited (ASX: CYP.AX)
CytoDyn Inc. (OTC BB: CYDY)
CytoSorbents Corporation (NASDAQ: CTSO)
CytRx Corporation (NASDAQ: CYTR)
DARA BioSciences, Inc. (NASDAQ: DARA)
Delcath Systems, Inc. (NASDAQ: DCTH)
DelMar Pharmaceuticals, Inc. (OTCQX: DMPI)
DiaMedica Inc. (OTCQB: DMCAF)
Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX)
Dot Hill Systems Corp. (NASDAQ: HILL)
DragonWave Inc. (NASDAQ: DRWI)
DURECT Corporation (NASDAQ: DRRX)
Echo Therapeutics, Inc. (NASDAQ: ECTE)
EDAP TMS S.A. (NASDAQ: EDAP)
Elite Pharmaceuticals, Inc. (OTCQB: ELTP)
eMagin Corporation (NYSE MKT: EMAN)
Emisphere Technologies, Inc. (OTC BB: EMIS)
Energy Fuels Inc. (TXX & NYSEMKT: EFR.TO)
Eyegate Pharmaceuticals, Inc. (OTC BB: EYEG)
Fate Therapeutics, Inc. (NASDAQ: FATE)
Finjan Holdings, Inc. (NASDAQ: FNJN)
Fission Uranium Corp. (TSX: FCU.TO)
Flex Pharma, Inc. (NASDAQ: FLKS)
FlexShopper, Inc. (OTCQB: FPAY)
Galectin Therapeutics Inc. (NASDAQ: GALT)
Galena Biopharma, Inc. (NASDAQ: GALE)
GenSpera Inc. (OTCQB: GNSZ)
Geodrill Limited (TSX: GEO.TO)
GeoVax Labs, Inc. (OTCQB: GOVX)
Global Blood Therapeutics
GoGold Resources Inc. (Toronto: GGD.TO)
Golden Minerals Company (NYSE MKT: AUMN)
Great Panther Silver Limited (NYSE MKT: GPR.TO)
Heat Biologics, Inc. (NASDAQ: HTBX)
Hecla Mining Company (NYSE: HL)
Immune Pharmaceuticals, Inc. (NASDAQ: IMNP)
Immunomedics, Inc. (NASDAQ: IMMU)
Imugene Limited (ASX: IMU.AX)
Information Services Group, Inc. (NASDAQ: III)
Inovio Pharmaceuticals, Inc. (NASDAQ: INO)
IntelGenx (OTC: IGXT)
International Stem Cell Corporation (OTCQB: ISCO)
Inuvo, Inc. (NYSE MKT: INUV)
Inventergy Global, Inc. (NASDAQ: INVT)
InVivo Therapeutics Holdings Corp. (OTC BB: NVIV)
Kadmon
Kaizen Discovery Inc. (TSX.V: KZD.V)
Kamada Ltd. (NASDAQ: KMDA)
La Jolla Pharmaceutical Company (NASDAQ: LJPC)
Liquidmetal Technologies, Inc. (OTC BB: LQMT)
MAG Silver Corp. (TSX: MAG.TO)
Magic Software Enterprises Ltd. (NASDAQ: MGIC)
Matinas BioPharma Holdings, Inc. (OTCQB: MTNB)
Mayne Pharma Group Limited (ASX: MYX.AX)
MDxHealth SA (OTC BB: MXDHF)
Merus Labs International Inc. (NASDAQ: MSLI)
MicroVision, Inc. (NASDAQ: MVIS)
Motif Bio plc (LSE: MTFB.L)
NanoViricides, Inc. (NYSE MKT: NNVC)
Neovacs S.A. (NYSE Alternext: ALNEV.PA)
NephroGenex, Inc. (NASDAQ: NRX)
NeuroMetrix, Inc. (NASDAQ: NURO)
NioCorp Developments, Ltd. (TSX: NB)
NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY)
Novatel Wireless Inc. (NASDAQ: NVTL)
Nuvo Research Inc. (TSX: NRI.TO)
Ocean Power Technologies, Inc. (NASDAQ: OPTT)
Oculus Innovative Sciences, Inc. (NASDAQ: OCLS)
Onconova Therapeutics, Inc. (NASDAQ: ONTX)
OncoSec Medical Incorporated (OTCQB: ONCS)
Oncothyreon Inc. (NASDAQ: ONTY)
Opexa Therapeutics, Inc. (NASDAQ: OPXA)
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP)
OXiGENE, Inc. (NASDAQ: OXGN)
Perseon Corporation (NASDAQ: PRSN)
Pershing Gold Corporation (OTCQB: PGLC)
Pixium Vision SA (Euronext Paris: PIX.PA)
PolyMet Mining Corp. (NYSE MKT: PLM)
Prescient Therapeutics Limited (ASX: VHL.AX)
Prima BioMed Ltd. (NASDAQ: PBMD)
Protalex, Inc. (OTC BB: PRTX)
Pure Bioscience, Inc. (OTCQB: PURE)
Radcom Ltd. (NASDAQ: RDCM)
RealNetworks Inc. (NASDAQ: RNWK)
RedHill Biopharma Ltd. (NASDAQ: RDHL)
RestorGenex Corporation (OTCQB: RESX)
Resverlogix Corp. (TSX: RVX.TO)
Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN)
Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI)
Rosetta Genomics Ltd. (NASDAQ: ROSG)
Safeguard Scientifics, Inc. (NYSE: SFE)
Signal Genetics, Inc. (NASDAQ: SGNL)
SITO Mobile Ltd. (OTC BB: SITO)
Solar3D, Inc. (NASDAQ: SLTD)
Sorrento Therapeutics, Inc. (NASDAQ: SRNE)
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
SteadyMed Ltd. (NASDAQ: STDY)
Stellar Biotechnologies, Inc. (OTCQB: SBOTF)
StemCells, Inc. (NASDAQ: STEM)
Stevia First Corp. (OTC BB: STVF)
Tecogen Inc. (NASDAQ: TGEN)
Threshold Pharmaceuticals, Inc. (NASDAQ: THLD)
Titan Pharmaceuticals, Inc. (OTCQB: TTNP)
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
Top Image Systems Ltd. (NASDAQ: TISA)
UQM Technologies, Inc. (NYSE MKT: UQM)
Ur-Energy Inc. (NYSE MKT: URG)
Uranium Energy Corp. (NYSE MKT: UEC)
VBI Vaccines Inc. (Nasdaq: VBIV)
Verastem, Inc. (NASDAQ: VSTM)
Vical Incorporated (NASDAQ: VICL)
Viggle Inc. (NASDAQ: VGGL)
Vista Gold Corp. (NYSE MKT: VGZ)
VolitionRX Limited (NYSE MKT: VNRX)
Vuzix Corporation (OTC BB: VUZI)
XTL Pharmaceuticals Ltd (Nasdaq: XTLB)

CONFERENCE SPONSORS

Marquee Sponsor

H.C. WAINWRIGHT & CO, LLC

Gold Sponsors

Blender; Marcum LLP

Silver Sponsors

Ellenoff Grossman & Schole LLP; Equities.com; Haynes and Boone, LLP; IRTH Communications; theIRapp®; Vintage

Bronze Sponsors

Bloomberg Brief; NASDAQ

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rodman--renshaw-2015-annual-global-investment-conference-to-be-held-in-new-york-from-september-8-to-10-2015-300110562.html

SOURCE Rodman & Renshaw Conferences, LLC

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.